Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet activation by platelet aggregation factor from Eisenia foelide

R Qian1, Y C Zhou, Q Q Zhuang

  • 1Shanghai Institute of Biochemistry, Chinese Academy of Sciences.

Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica
|September 1, 1994
PubMed
Summary

A novel earthworm factor, Eisenia foetida platelet-activating factor (EPAF), potently aggregates human platelets. This aggregation is independent of adenosine diphosphate and thromboxane A2, suggesting a unique mechanism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

[Lingual mucosal graft ureteroplasty for long (≥5 cm) proximal ureteral stricture: a multi-institutional 8-year experience].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025
Same author

[Study of the effect of self-perceived hearing status on depression in middle-aged and older people in the community].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

[Clinical analysis of splenic circulation control technology applied in minimally invasive radical resection of pancreatic neck and body cancer].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2025

Area of Science:

  • Biochemistry
  • Pharmacology
  • Zoology

Background:

  • Platelet aggregation is crucial for hemostasis and thrombosis.
  • Understanding novel platelet agonists can reveal new therapeutic targets.
  • Earthworms possess unique bioactive compounds with potential pharmacological activities.

Purpose of the Study:

  • To investigate the platelet-activating properties of a factor from Eisenia foetida (EPAF).
  • To characterize the mechanism of EPAF-induced human platelet aggregation.
  • To determine the independence of EPAF-induced aggregation from common pathways.

Main Methods:

  • Isolation and characterization of EPAF from Eisenia foetida.
  • Induction of human platelet aggregation using varying concentrations of EPAF.

Related Experiment Videos

  • Assessment of 5-hydroxytryptamine (5-HT) release.
  • Evaluation of inhibition by creatine phosphate/creatine phosphate kinase (CP/CPK) and aspirin.
  • Testing EPAF-induced aggregation in thrombin-treated, degranulated platelets with fibrinogen.

    • Main Results:

    • EPAF induced significant human platelet aggregation and 5-HT release.
    • Neither CP/CPK nor aspirin completely inhibited EPAF-induced aggregation.
    • EPAF induced aggregation in degranulated platelets, indicating potent agonist activity.
    • The aggregation was independent of adenosine diphosphate (ADP) and thromboxane A2 (TXA2).

    Conclusions:

    • EPAF is a potent platelet agonist with a unique mechanism of action.
    • EPAF-induced platelet aggregation is independent of ADP and TXA2 pathways.
    • EPAF represents a novel target for understanding platelet activation and potential therapeutic interventions.